|
Correction of Myopia Evaluation Trial (COMET) Clinical Trials Information presented on Clinical Trials Search is not intended to be a substitute for qualified health advice, trips or treatment by using a genuine doctor. We aren't doctors. Always consult your mD on Correction of Myopia Evaluation Trial (COMET) conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Correction of Myopia Evaluation Trial (COMET) Clinical research trials and Correction of Myopia Evaluation Trial (COMET) health trials take place in a lot of of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / projects is to answer specific human medical questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, like Correction of Myopia Evaluation Trial (COMET). Correction of Myopia Evaluation Trial (COMET) Clinical Trials and other clinical trials allow for volunteers to have health treatment alternatives before they are available to the general public. Many times the test subjects obtain treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Correction of Myopia Evaluation Trial (COMET) clinical trial. Subjects oftentimes recieve the most effective healthcare possible for their Correction of Myopia Evaluation Trial (COMET) condition. Hazards are a reality, however, and could include additional or frequent doctor visits, healthcare dangers (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Correction of Myopia Evaluation Trial (COMET)  Correction of Myopia Evaluation Trial (COMET)
Correction of Myopia Evaluation Trial (COMET)
For Condition: Myopia
Status: No longer recruiting
Sponsor(s): National Eye Institute (NEI) ,
Synopsis: To evaluate whether progressive addition lenses (PALs) slow the rate of progression of juvenile-onset myopia (nearsightedness) when compared with single vision lenses, as measured by cycloplegic autorefraction. An additional outcome measure is axial length, as measured by A-scan ultrasonography. To describe the natural history of juvenile-onset myopia in a group of children receiving conventional treatment (single vision lenses).
Details: Myopia (nearsightedness) is an important public health problem, which entails substantial societal and personal costs. It is highly prevalent in our society and even more frequent in Asian countries; furthermore, its prevalence may be increasing over time. High myopia contributes to significant loss of vision and blindness. At present, the mechanisms involved in the etiology of myopia are unclear, and there is no way to prevent the condition. Current methods of correction require lifelong use of lenses or surgical treatment, which is expensive and may lead to complications. The rationale for this trial, the Correction of Myopia Evaluation Trial (COMET), arises from the convergence of research involving (1) the link between accommodation and myopia in children and (2) animal models of myopia showing the important role of the visual environment in eye growth. A contribution of this research is that blur is a critical component in the development of myopia. The primary aim of COMET, to evaluate the efficacy of progressive addition lenses, a noninvasive intervention, in slowing the progression of myopia, follows from this line of reasoning. These lenses should provide clear visual input over a range of viewing distances without focusing effort by the child. The comparison of myopia progression in children treated with PALs versus single vision lenses will allow the quantification of the effect of PALs on myopia progression during the followup period. The COMET is a multicenter, randomized, double-masked clinical trial to evaluate whether PALs slow the progression of juvenile-onset myopia as compared with single vision lenses. The study is a collaborative effort that involves a Study Chair at the New England College of Optometry; four clinical centers at colleges of optometry in Boston, Birmingham, Philadelphia, and Houston; and a Coordinating Center at the State University of New York at Stony Brook. The sample size goal, 450 children with myopia in both eyes who met specific inclusion and exclusion criteria, was attained with the enrollment of 469 children in one year. Children were identified from school screenings, clinic records, and referrals from local practitioners. Eligible children were randomly assigned to receive progressive addition or single vision lenses. Participating children are being examined at 6-month intervals following baseline, for at least 3 years, to measure changes in refractive error and to update prescriptions, according to a specified protocol. A dilated examination to evaluate the study outcome measures is performed at the annual study visits. A standardized, common protocol is used at all centers. The primary outcome of the study is progression of myopia, defined as the magnitude of the change relative to baseline in spherical equivalent refraction, determined by cycloplegic autorefraction. The secondary outcome of the study is axial length measured by A-scan ultrasonography.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind
Minimum Age/Maximum Age: 6 Years/12 Years
Genders: Both
Protocol Entry Criteria: Children between the ages of 6 and 12 years with myopia in both eyes (defined as spherical equivalent between -1.25 D and -4.50 D in each eye as measured by cycloplegic autorefraction), astigmatism less than or equal to 1.50 D, and no anisometropia (defined as a difference in spherical equivalent between the two eyes greater than 1.0 D) are eligible for inclusion. Exclusion criteria include visual acuity greater than 20/25, strabismus, use of contact lenses, birth weight less than 1,250 grams, use of bifocal or progressive addition lenses, or any conditions precluding adherence to the protocol.
Total Enrollment:
Location and Contact Information:
Pennsylvania College of Optometry
Philadelphia, Pennsylvania, 19141-3399
United States
University of Alabama-Birmingham, School of Optometry
Birmingham, Alabama, 35294-0010
United States
New England College of Optometry
Boston, Massachusetts, 02115
United States
University of Houston, College of Optometry
Houston, Texas, 77204-6052
United States
Additional Information:
Study ID Numbers: NEI-9;
Study Start Date: September 1997
Record last reviewed: October 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000113
Other Myopia Studies:
1. A Trial of Bifocals in Myopic Children With Esophoria
2. The Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study
3. Correction of Myopia Evaluation Trial (COMET)
Related Studies:
Other Myopia Clinical Trials
Other Texas Clinical Trials
Other Houston Clinical Trials
Correction of Myopia Evaluation Trial (COMET)
|
|
|
|
|
|
|
|
